Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin Rinse for Oral Mucositis Pain
NCT01156142Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxepin in oral mucositis (OM), sponsored by Cancer and Leukemia Group B. Started Dec 2010; status: completed.
02
Drugs
doxepin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT01156142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156142.